ClinicalTrials.Veeva

Menu

Leucine Supplementation in Elderly Men

Maastricht University Medical Centre (MUMC) logo

Maastricht University Medical Centre (MUMC)

Status and phase

Completed
Phase 2
Phase 1

Conditions

Aging
Atrophy
Sarcopenia

Treatments

Dietary Supplement: placebo
Dietary Supplement: leucine

Study type

Interventional

Funder types

Other

Identifiers

NCT00807508
MEC 06-3-062A

Details and patient eligibility

About

In the present study the investigators aim to determine whether leucine supplementation can augment muscle mass and strength and improve body composition in healthy elderly men

Enrollment

29 patients

Sex

Male

Ages

65 to 85 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • living independently

Exclusion criteria

  • Diabetes cardiovascular disease orthopedic limitations history of resistance training in past 5 years

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

29 participants in 2 patient groups, including a placebo group

1
Experimental group
Description:
daily leucine supplementation
Treatment:
Dietary Supplement: leucine
2
Placebo Comparator group
Description:
daily placebo supplementation
Treatment:
Dietary Supplement: placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems